ETV6-NTRK3, which had been identified as a causative fusion oncogene in over 90% of secretary breast cancer samples, encodes a dimerization domain of the ETV6 transcription factor, conjoined to kinase domain of NTRK3 [15]. This evidence concerns the gene ETV6 and breast cancer.